Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 4.68K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TERN | Terns Pharmaceuticals, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
TERN | Terns Pharmaceuticals, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
TERN | Terns Pharmaceuticals, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
TERN | Terns Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
TERN | Terns Pharmaceuticals, Inc. | Sep 28, 2021 | 1 | $0 | 4 | Oct 12, 2021 | Director |
TERN | Terns Pharmaceuticals, Inc. | Sep 28, 2021 | 0 | $0 | 3 | Oct 12, 2021 | Director |